Dr. Paul Paik
Claim this profileMemorial Sloan Kettering Westchester (All Protocol Activities)
Studies Lung Cancer
Studies Relapse
6 reported clinical trials
12 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
NFE2L2
2Relapse
Stage IV
NFE2L2
NSD3 positive
Affiliated Hospitals
Clinical Trials Paul Paik is currently running
Certolizumab + Chemotherapy + Nivolumab
for Lung Cancer
The purpose of the study is to explore adding the study drug certolizumab to standard chemotherapy as it may reduce the inflammation caused by the cancer and make the chemotherapy more effective in shrinking the cancer. This study will examine whether adding certolizumab to the usual treatment approach is better than, the same as, or worse than the usual approach alone.
Recruiting1 award Phase 214 criteria
ZEN003694
for Squamous Cell Lung Cancer
The purpose of this study is to find out whether ZEN003694 is an effective treatment for people with advanced squamous cell lung cancer with a mutation in the NSD3 gene. ZEN003694 is a type of drug called a BET inhibitor. Researchers think ZEN003694 may help here because the drug works by blocking a group of proteins called bromodomain and extra-terminal (BET) proteins, which may counteract the effect of NSD3 on tumor growth. Blocking these proteins may slow or stop the growth of the cancer.
Recruiting1 award Phase 2
More about Paul Paik
Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Paul Paik has experience with
- Carboplatin
- Pemetrexed
- ZEN003694
- Certolizumab
- Cisplatin
- Gemcitabine
Breakdown of trials Paul Paik has run
Lung Cancer
Relapse
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Paik specialize in?
Paul Paik focuses on Lung Cancer and Relapse. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul Paik currently recruiting for clinical trials?
Yes, Paul Paik is currently recruiting for 3 clinical trials in Harrison New York. If you're interested in participating, you should apply.
Are there any treatments that Paul Paik has studied deeply?
Yes, Paul Paik has studied treatments such as Carboplatin, Pemetrexed, ZEN003694.
What is the best way to schedule an appointment with Paul Paik?
Apply for one of the trials that Paul Paik is conducting.
What is the office address of Paul Paik?
The office of Paul Paik is located at: Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York 10604 United States. This is the address for their practice at the Memorial Sloan Kettering Westchester (All Protocol Activities).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.